Blog
Provocholine®
Aridol®
Partnerships
Training
Clinical Research Consultation
CRCE Courses
Blogs / Podcast
Guidelines / Publications
Speaking Engagements
Welcome to Our Blog
Methapharm Respiratory is proud to work with healthcare practitioners to support the right diagnosis for patients exhibiting common respiratory symptoms such as cough, wheeze, and shortness of breath. We are a trusted partner for bronchoprovocation testing, supplying Provocholine and Aridol. We also offer training and education (CRCE) at no cost.
This blog is intended to be an additional resource to the education Methapharm currently offers through the American Association for Respiratory Care (AARC) and the Canadian Society of Respiratory Therapists (CSRT) approved CRCEs. While this blog will not provide education credits, it will explore current issues and interesting topics relevant to readers’ day-to-day work and personal lives. We hope that you will investigate further any of the topics we cover here. Please join us monthly as we share respiratory-related topics and beyond.
Artificial Intelligence in Pulmonary
Artificial Intelligence (AI) is a hot, and controversial, topic of conversation. Its applications in medicine are in the early stages, however, AI is not new. In 1950, a paper was published titled “Computer Machinery and Intelligence.” In 1952 Arthur Samuel, a...
Recent Posts
Artificial Intelligence in Pulmonary
Artificial Intelligence (AI) is a hot, and controversial, topic of conversation. Its applications in medicine are in the early stages, however, AI is not new. In 1950, a paper was published titled “Computer Machinery and Intelligence.” In 1952 Arthur Samuel, a...
Understanding Methacholine Chloride
For most Respiratory Therapists, and other health care workers in pulmonary diagnostics, methacholine chloride is a common, well-known bronchoprovocation agent. Provocholine® is the only FDA cleared methacholine chloride available for the methacholine challenge test...
Broken Heart Syndrome
What is “broken heart syndrome?” The medical term for broken heart syndrome is Takotsubo Cardiomyopathy. It was first described in 1990 by a Japanese physician, Dr. Hikaru Sato. He described a series of patients who presented as if they were having a heart attack...